Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Price (Quote)

$1.23
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $1.23 $1.23 Friday, 27th May 2022 CTRV stock ended at $1.23. During the day the stock fluctuated 0% from a day low at $1.23 to a day high of $1.23.
90 days $0.94 $1.27
52 weeks $0.86 $2.32

Historical ContraVir Pharmaceuticals Inc prices

Date Open High Low Close Volume
Dec 12, 2016 $1,108.80 $1,120.00 $1,069.60 $1,097.60 651
Dec 09, 2016 $1,120.00 $1,136.80 $1,097.60 $1,108.80 850
Dec 08, 2016 $1,176.00 $1,198.40 $1,092.00 $1,125.60 4 492
Dec 07, 2016 $1,108.80 $1,125.60 $1,103.20 $1,114.40 563
Dec 06, 2016 $1,136.80 $1,136.80 $1,097.60 $1,120.00 549
Dec 05, 2016 $1,125.60 $1,142.40 $1,092.00 $1,142.40 724
Dec 02, 2016 $1,103.20 $1,120.00 $1,080.80 $1,120.00 475
Dec 01, 2016 $1,103.20 $1,159.20 $1,075.20 $1,114.40 1 023
Nov 30, 2016 $1,159.20 $1,159.20 $1,108.80 $1,108.80 1 058
Nov 29, 2016 $1,164.80 $1,176.00 $1,120.00 $1,164.80 1 061
Nov 28, 2016 $1,170.40 $1,232.00 $1,142.40 $1,170.40 1 452
Nov 25, 2016 $1,153.60 $1,198.40 $1,136.80 $1,164.80 941
Nov 23, 2016 $1,131.20 $1,153.60 $1,097.60 $1,153.60 878
Nov 22, 2016 $1,120.00 $1,142.40 $1,075.20 $1,142.40 1 085
Nov 21, 2016 $1,288.00 $1,299.20 $1,120.00 $1,125.60 5 039
Nov 18, 2016 $1,114.40 $1,204.00 $1,114.40 $1,192.80 4 079
Nov 17, 2016 $1,148.00 $1,159.20 $1,103.20 $1,125.60 511
Nov 16, 2016 $1,136.80 $1,136.80 $1,097.60 $1,131.20 1 120
Nov 15, 2016 $1,176.00 $1,181.60 $1,108.80 $1,136.80 1 106
Nov 14, 2016 $1,064.00 $1,148.00 $1,058.40 $1,148.00 1 423
Nov 11, 2016 $1,108.80 $1,136.80 $1,064.00 $1,069.60 1 743
Nov 10, 2016 $1,148.00 $1,220.80 $1,114.40 $1,125.60 1 706
Nov 09, 2016 $1,069.60 $1,153.60 $1,069.60 $1,131.20 1 109
Nov 08, 2016 $1,103.20 $1,148.00 $980.00 $1,142.40 1 193
Nov 07, 2016 $1,108.80 $1,153.60 $1,108.80 $1,120.00 1 411
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT